The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

BACKGROUND: Pancreatic cancer (PC) patients have multiple risk factors for sarcopenia and loss of skeletal muscle mass (LSMM), which may cause greater treatment toxicities, reduced response to cancer therapy, prolonged hospitalization, impaired quality of life, and worse prognosis. METHODS: This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Debora, Parnofiello, Annamaria, Vitale, Maria Grazia, Cortiula, Francesco, Gerratana, Lorenzo, Fanotto, Valentina, Lisanti, Camilla, Pelizzari, Giacomo, Ongaro, Elena, Bartoletti, Michele, Garattini, Silvio Ken, Andreotti, Victoria Josephine, Bacco, Anna, Iacono, Donatella, Bonotto, Marta, Casagrande, Mariaelena, Ermacora, Paola, Puglisi, Fabio, Pella, Nicoletta, Fasola, Gianpiero, Aprile, Giuseppe, Cardellino, Giovanni G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463465/
https://www.ncbi.nlm.nih.gov/pubmed/30719874
http://dx.doi.org/10.1002/jcsm.12368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463465/
https://www.ncbi.nlm.nih.gov/pubmed/30719874
http://dx.doi.org/10.1002/jcsm.12368

Ejemplares similares